PH25251A - Preparation of polypeptides having human gamma interferon activity - Google Patents

Preparation of polypeptides having human gamma interferon activity

Info

Publication number
PH25251A
PH25251A PH32148A PH32148A PH25251A PH 25251 A PH25251 A PH 25251A PH 32148 A PH32148 A PH 32148A PH 32148 A PH32148 A PH 32148A PH 25251 A PH25251 A PH 25251A
Authority
PH
Philippines
Prior art keywords
polypeptides
preparation
gamma interferon
human gamma
sequences
Prior art date
Application number
PH32148A
Other languages
English (en)
Inventor
Joachim Engels
Michael Leineweber
Wolfgang Ulmer
Eugen Uhlmann
Original Assignee
Hoechst Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoechst Ag filed Critical Hoechst Ag
Publication of PH25251A publication Critical patent/PH25251A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/555—Interferons [IFN]
    • C07K14/57—IFN-gamma
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S435/00—Chemistry: molecular biology and microbiology
    • Y10S435/811—Interferon
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/142—Interferon

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
PH32148A 1984-04-19 1985-04-18 Preparation of polypeptides having human gamma interferon activity PH25251A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19843414831 DE3414831A1 (de) 1984-04-19 1984-04-19 Herstellung von polypeptiden mit human-gammainterferon-aktivitaet

Publications (1)

Publication Number Publication Date
PH25251A true PH25251A (en) 1991-03-27

Family

ID=6234006

Family Applications (1)

Application Number Title Priority Date Filing Date
PH32148A PH25251A (en) 1984-04-19 1985-04-18 Preparation of polypeptides having human gamma interferon activity

Country Status (20)

Country Link
US (1) US4832959A (fr)
EP (1) EP0161504B1 (fr)
JP (2) JPH0745516B2 (fr)
KR (1) KR920009505B1 (fr)
AT (1) ATE69241T1 (fr)
CA (1) CA1339892C (fr)
DE (2) DE3414831A1 (fr)
DK (1) DK164940C (fr)
ES (1) ES8603574A1 (fr)
FI (1) FI90436C (fr)
GR (1) GR850941B (fr)
HU (1) HU210111B (fr)
IE (1) IE59460B1 (fr)
IL (1) IL74947A (fr)
MA (1) MA20411A1 (fr)
NO (1) NO171983C (fr)
NZ (1) NZ211827A (fr)
PH (1) PH25251A (fr)
PT (1) PT80300B (fr)
ZA (1) ZA852900B (fr)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3409966A1 (de) * 1984-03-19 1985-09-26 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-gammainterferon und mittel zur durchfuehrung dieses verfahrens
DE3536939A1 (de) * 1985-10-17 1987-04-23 Hoechst Ag Biologisch aktive derivate des human-(gamma)-interferons, ihre herstellung und arzneimittel, die solche derivate enthalten
GB8619725D0 (en) * 1986-08-13 1986-09-24 Hoffmann La Roche Homogenous interferon fragments
DE3642096A1 (de) * 1986-12-10 1988-06-16 Boehringer Ingelheim Int Pferde-(gamma)-interferon
JP2653061B2 (ja) * 1986-12-27 1997-09-10 武田薬品工業株式会社 新規ポリペプチドおよびその製造法
US5157004A (en) * 1986-12-27 1992-10-20 Takeda Chemical Industries, Ltd. Polypeptides and production thereof
JP2003513681A (ja) 1999-11-12 2003-04-15 マキシゲン・ホールディングス・リミテッド インターフェロンガンマ・コンジュゲート
CN1309423C (zh) 1999-11-12 2007-04-11 马克西根控股公司 干扰素γ偶联物
US6958388B2 (en) 2001-04-06 2005-10-25 Maxygen, Aps Interferon gamma polypeptide variants
US7038015B2 (en) * 2001-04-06 2006-05-02 Maxygen Holdings, Ltd. Interferon gamma polypeptide variants
US7524931B2 (en) * 2002-07-03 2009-04-28 Maxygen Holdings Ltd. Full-length interferon gamma polypeptide variants
US20050003533A1 (en) 2003-05-08 2005-01-06 Pawel Kalinski Mature type-1 polarized dendritic cells with enhanced IL-12 production and methods of serum-free production and use
BG66458B1 (bg) 2005-03-21 2014-10-31 Иван Иванов Средство за конкурентно инхибиране на ендогенен гама интерферон
EP1877434A2 (fr) * 2005-05-04 2008-01-16 Nautilus Biotech Polypeptides d'interferon-gamma modifies et procedes d'utilisation de polypeptides d'interferon-gamma modifies
WO2008121461A2 (fr) * 2007-02-26 2008-10-09 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Vaccin pour activer la fonction auxiliaire des lymphocytes t cd8+
US9359421B2 (en) 2008-04-08 2016-06-07 Tigo Gmbh Suppressor of the endogenous interferon-gamma
BG66517B1 (bg) * 2008-04-08 2016-02-29 Tigo Gmbh Супресор на ендогенния човешки гама - интерферон
JP4821891B2 (ja) * 2009-07-01 2011-11-24 トヨタ自動車株式会社 電池制御システム及び車両
BG67190B1 (bg) 2017-03-29 2020-11-16 Tigo Gmbh Анти-гама мутантен протеин срещу ендогенния човешки гама интерферон
TW202028245A (zh) 2018-10-11 2020-08-01 美商英伊布里克斯公司 Dll3單域抗體及其治療性組合物
WO2020076970A1 (fr) 2018-10-11 2020-04-16 Inhibrx, Inc. Anticorps b7h3 à domaine unique et compositions thérapeutiques associées
TW202021986A (zh) 2018-10-11 2020-06-16 美商英伊布里克斯公司 5t4單域抗體及其治療性組合物
AU2019356573A1 (en) 2018-10-11 2021-05-27 Inhibrx Biosciences, Inc. PD-1 single domain antibodies and therapeutic compositions thereof

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU561343B2 (en) * 1981-10-19 1987-05-07 Genentech Inc. Human immune interferon by recombinant dna
JPS58110548A (ja) * 1981-12-24 1983-07-01 Asahi Chem Ind Co Ltd 新規な生理活性ペプチド
ZA831094B (en) * 1982-02-22 1983-11-30 Biogen Nv Dna sequences,recombinant dna molecules and processes for producing human immune interferon-like polypeptides
IL68100A0 (en) * 1982-03-24 1983-06-15 Takeda Chemical Industries Ltd Novel dna and use thereof
US6936694B1 (en) * 1982-05-06 2005-08-30 Intermune, Inc. Manufacture and expression of large structural genes
JPH0787797B2 (ja) * 1982-05-20 1995-09-27 サントリー株式会社 ヒト・ガンマ・インタ−フエロン様ポリペプチドの製造法
US4681848A (en) * 1982-09-22 1987-07-21 Takeda Chemical Industries, Ltd. Novel peptide and use thereof
US4604284A (en) * 1983-09-20 1986-08-05 Hoffmann-La Roche Inc. Homogeneous immune interferon fragment
US4855238A (en) * 1983-12-16 1989-08-08 Genentech, Inc. Recombinant gamma interferons having enhanced stability and methods therefor

Also Published As

Publication number Publication date
DE3414831A1 (de) 1985-10-31
DK176285A (da) 1985-10-20
DK164940C (da) 1993-02-01
HUT37815A (en) 1986-02-28
JPH07100037B2 (ja) 1995-11-01
HU210111B (en) 1995-02-28
ES542337A0 (es) 1985-12-16
MA20411A1 (fr) 1985-12-31
KR920009505B1 (ko) 1992-10-17
IE850995L (en) 1985-10-19
FI851529L (fi) 1985-10-20
FI90436C (fi) 1994-02-10
DK164940B (da) 1992-09-14
PT80300B (pt) 1987-09-30
FI851529A0 (fi) 1985-04-17
IL74947A0 (en) 1985-08-30
NO171983C (no) 1993-05-26
EP0161504B1 (fr) 1991-11-06
ZA852900B (en) 1985-11-27
FI90436B (fi) 1993-10-29
GR850941B (fr) 1985-11-25
US4832959A (en) 1989-05-23
NZ211827A (en) 1988-07-28
PT80300A (de) 1985-05-01
EP0161504A1 (fr) 1985-11-21
JPH0745516B2 (ja) 1995-05-17
JPS60233100A (ja) 1985-11-19
IL74947A (en) 2000-06-01
JPH06153957A (ja) 1994-06-03
CA1339892C (fr) 1998-06-02
NO171983B (no) 1993-02-15
NO851564L (no) 1985-10-21
ES8603574A1 (es) 1985-12-16
DE3584579D1 (de) 1991-12-12
IE59460B1 (en) 1994-02-23
DK176285D0 (da) 1985-04-18
KR850007274A (ko) 1985-12-02
ATE69241T1 (de) 1991-11-15

Similar Documents

Publication Publication Date Title
IL74947A0 (en) Preparation of polypeptides having human gamma interferon activity
GR3017535T3 (en) Live vaccines.
FR2681786B1 (fr)
FI853056L (fi) Menetelmä hirudiinin vaikutusta omaavan polypeptidin valmistamiseksi
ZA909762B (en) Process for the production of biologically active protein
ZA884216B (en) Proteins with factor viii activity,process for their preparation and pharmaceutical compositions containing them
EP0226448A3 (en) Solubilisation of protein aggregates
NZ221119A (en) Proteins with factor viii activity produced by microorganisms produced by genetic engineering
EP0237966A3 (fr) Facteur humain basique de croissance de fibroblaste
IL81018A (en) Fusion proteins comprising small fragments of human interleukin-2 as ballast,process for its preparation and genes,vectors and transformed host containing said fragments and used in the process
IL81221A0 (en) Dna sequences coding for proteins having the biological activity of husi-type i inhibitors,biotechnological methods for preparing said proteins and pharmaceutical compositions containing them
EP0163249A3 (en) Gene-technological process for the preparation of human interleukin-2, and device for carrying out this process
HUT42102A (en) Process for preparing peptides with pharmaceutical activity
ATE145939T1 (de) Mitogen für die glatte muskulatur und dessen kodierende dns
ES8603571A1 (es) Un procedimiento para preparar gamma-interferon de humano
UA5743C2 (uk) Препарат тканинних біологічно активних речовин, який має регенаторну дію, та спосіб його одержання
BG60106B2 (bg) Метод за култивиране на водорасли